Skip to main content

Feldman v. Lederle Laboratories

Citations

  • 479 A.2d 374
  • 97 N.J. 429
  • 39 U.C.C. Rep. Serv. (West) 866
  • 14 Envtl. L. Rep. (Envtl. Law Inst.) 20855
  • 1984 N.J. LEXIS 2727

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding that a drug manufacturer is not deemed to know of the dangerous propensity of its product when the danger is unknowable
  • ruling that regulation by Food and Drug Administration of drug industry does not relieve drug manufacturers of duty to provide adequate warnings concerning harmful risks of their products
  • ruling that regulation by Food and Drug Administration of drug industry does not relieve drug manufacturers of duty to provide adequate warnings concerning harmful risks of their products
  • stating that \[w]hen the strict liability defect consists of an improper design ... reasonableness of the defendant's conduct is a factor in determining liability\
  • noting that “strict liability analysis becomes almost identical to negligence analysis in its focus on the reasonableness of defendant’s conduct”
  • noting that “strict liability analysis becomes almost identical to negligence analysis in its focus on the reasonableness of defendant’s conduct”

Source: CourtListener parenthetical corpus (CC0).

Judges: Schreiber

Read full opinion on CourtListener

Cited by

161 cases in this archive cite this case; the 20 most cited are listed.

Cites

59 cases in this archive are cited by this case; the 20 most cited are listed.

Other cases named Feldman v. Lederle Laboratories

7 other CourtListener records share this case name.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.